Melanin-like nanoparticles as a potential novel therapeutic approach in ADPKD
In this issue of EMBO Molecular Medicine, Sun and colleagues report the development of a novel therapeutic approach, and preclinical proof-of-concept evidence of its efficacy, for Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Sun et al, 2024).
Saved in:
Main Authors: | Laura Cassina, Alessandra Boletta |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2024-11-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.1038/s44321-024-00173-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melanin-like nanoparticles slow cyst growth in ADPKD by dual inhibition of oxidative stress and CREB
by: Yongzhan Sun, et al.
Published: (2024-11-01) -
Preclinical pharmaco-toxicological screening of biomimetic melanin-like nanoparticles as a potential therapeutic strategy for cutaneous melanoma
by: Iasmina Marcovici, et al.
Published: (2025-02-01) -
Unexpected Abscess Localization of the Anterior Abdominal Wall in an ADPKD Patient Undergoing Hemodialysis
by: Nikos Sabanis, et al.
Published: (2015-01-01) -
End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
by: Hiroaki Hanafusa, et al.
Published: (2024-03-01) -
Quercetin nanoparticles as a therapeutic approach:
pharmacological actions and potential applications in therapy
by: Reham Farouk El-Sayed Baiomy
Published: (2024-12-01)